UK Guidelines Quiz: Do You Know The Latest on Managing Lyme Disease?

Tim Locke

Disclosures

February 12, 2019

The 2019 guideline from NICE supports diagnosis and treatment of Lyme disease in patients with erythema migrans without first confirming a diagnosis with laboratory tests.

If this rash is not present then a combination of clinical assessment and serological testing should be used to guide diagnosis and treatment. However, the diagnosis should not be ruled out if tests are negative and where Lyme disease is highly suspected.

Oral doxycycline is recommended first line for patients aged 12 and over with erythema migrans and/or non-focal symptoms. Weight-related doses of doxycycline are recommended first line for children aged 9-12 with erythema migrans and/or non-focal symptoms, and weight-related doses of oral amoxicillin for children aged under 9 with erythema migrans and/or non-focal symptoms.

For patients with focal symptoms oral doxycycline, oral amoxicillin, or intravenous ceftriaxone, may be appropriate depending on individual circumstances and symptom presentation.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....